Are patients more adherent to newer drugs?
Author
Abstract
Suggested Citation
DOI: 10.1007/s10729-020-09513-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Gene M. Grossman & Elhanan Helpman, 1991.
"Quality Ladders in the Theory of Growth,"
The Review of Economic Studies, Review of Economic Studies Ltd, vol. 58(1), pages 43-61.
- Grossman, G.M. & Helpman, E., 1989. "Quality Ledders In The Theory Of Growth," Papers 148, Princeton, Woodrow Wilson School - Public and International Affairs.
- Gene M. Grossman & Elhanan Helpman, 1989. "Quality Ladders in the Theory of Growth," NBER Working Papers 3099, National Bureau of Economic Research, Inc.
- W. David Bradford & Andrew N. Kleit, 2015. "Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication," Health Economics, John Wiley & Sons, Ltd., vol. 24(7), pages 859-875, July.
- Daniel Smith & Christina Pagel & Martin Utley & Steve Gallivan, 2008. "Quantifying the impact of non-adherence to drug therapy: a technical note concerning an application of a branch and bound algorithm," Health Care Management Science, Springer, vol. 11(3), pages 302-305, September.
- repec:wly:hlthec:v:26:y:2017:i::p:106-126 is not listed on IDEAS
- Steve Gallivan & Christina Pagel & Martin Utley & Bryony Dean Franklin & Katja Taxis & Nick Barber, 2008. "A technical note concerning non-adherence to drug therapy: exact expressions for the mean and variance of drug concentration," Health Care Management Science, Springer, vol. 11(3), pages 296-301, September.
- Frank R. LICHTENBERG, 2018.
"The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries,"
JODE - Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
- Lichtenberg, Frank R., 2018. "The Impact Of New Drug Launches On Life-Years Lost In 2015 From 19 Types Of Cancer In 36 Countries," Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
- Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," Working Papers id:12757, eSocialSciences.
- Frank R. Lichtenberg, 2018. "The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," NBER Working Papers 24536, National Bureau of Economic Research, Inc.
- Vincenzo Atella & Federico Belotti & Domenico Depalo, 2017.
"Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity,"
Health Economics, John Wiley & Sons, Ltd., vol. 26(S2), pages 106-126, September.
- Vincenzo Atella & Federico Belotti & Domenico Depalo, 2011. "Drug therapy adherence and health outcomes in presence of physician and patient unobserved heterogeneity," CEIS Research Paper 186, Tor Vergata University, CEIS, revised 22 Jun 2017.
- Philippe Aghion & Steven Durlauf (ed.), 2005. "Handbook of Economic Growth," Handbook of Economic Growth, Elsevier, edition 1, volume 1, number 1.
- Frank Lichtenberg, 2012. "Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7," PharmacoEconomics, Springer, vol. 30(3), pages 197-211, March.
- Frank R. Lichtenberg, 2009.
"Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country‐level data on 20 OECD countries, 1995–2003,"
Health Economics, John Wiley & Sons, Ltd., vol. 18(5), pages 519-534, May.
- Frank R. Lichtenberg, 2008. "Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003," NBER Working Papers 14008, National Bureau of Economic Research, Inc.
- Jovanovic, Boyan & Yatsenko, Yuri, 2012. "Investment in vintage capital," Journal of Economic Theory, Elsevier, vol. 147(2), pages 551-569.
- Natalie Mizik & Robert Jacobson, 2004. "Are Physicians ÜEasy MarksÝ? Quantifying the Effects of Detailing and Sampling on New Prescriptions," Management Science, INFORMS, vol. 50(12), pages 1704-1715, December.
- Avery, Rosemary J. & Eisenberg, Matthew D. & Simon, Kosali I., 2012. "The impact of direct-to-consumer television and magazine advertising on antidepressant use," Journal of Health Economics, Elsevier, vol. 31(5), pages 705-718.
- Frank R. Lichtenberg, 2019. "How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013," NBER Working Papers 25483, National Bureau of Economic Research, Inc.
- Sujata Sapkota & Jo-anne E Brien & Jerry R Greenfield & Parisa Aslani, 2015. "A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes—Components of Interventions," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-30, June.
- Aghion, Philippe & Howitt, Peter, 2005. "Growth with Quality-Improving Innovations: An Integrated Framework," Handbook of Economic Growth, in: Philippe Aghion & Steven Durlauf (ed.), Handbook of Economic Growth, edition 1, volume 1, chapter 2, pages 67-110, Elsevier.
- Greenwood, Jeremy & Hercowitz, Zvi & Krusell, Per, 1997.
"Long-Run Implications of Investment-Specific Technological Change,"
American Economic Review, American Economic Association, vol. 87(3), pages 342-362, June.
- Greenwood, J. & Hercowitz, Z. & Krusell, P., 1995. "Long-Run Implications of Investment-Specific Technological Change," University of Western Ontario, Departmental Research Report Series 9510, University of Western Ontario, Department of Economics.
- Greenwood, J. & Hercowitz, Z. & Krusell, P., 1996. "Long-Run Implications of Investment-Specific Technological Change," RCER Working Papers 420, University of Rochester - Center for Economic Research (RCER).
- Toshiaki Iizuka, 2004. "What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs?," Journal of Industrial Economics, Wiley Blackwell, vol. 52(3), pages 349-379, September.
- Cardon & Showalter, 2015. "The effects of direct-to-consumer advertising of pharmaceuticals on adherence," Applied Economics, Taylor & Francis Journals, vol. 47(50), pages 5432-5444, October.
- Cameron Kaplan & Yuting Zhang, 2014. "The January Effect: Medication Reinitiation Among Medicare Part D Beneficiaries," Health Economics, John Wiley & Sons, Ltd., vol. 23(11), pages 1287-1300, November.
- Frank R. Lichtenberg, 2014. "The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010," Journal of Human Capital, University of Chicago Press, vol. 8(4), pages 432-480.
- Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley, 2001. "The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 601-615, October.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Di Novi, Cinzia & Leporatti, Lucia & Levaggi, Rosella & Montefiori, Marcello, 2022. "Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization," Journal of Economic Behavior & Organization, Elsevier, vol. 204(C), pages 1-14.
- Lucia Leporatti & Rosella Levaggi & Marcello Montefiori, 2021. "Beyond price: the effects of non-financial barriers on access to drugs and health outcomes," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 519-529, June.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Richard M. H. Suen, 2013.
"Research Policy and U.S. Economic Growth,"
Working papers
2013-18, University of Connecticut, Department of Economics.
- Suen, Richard M.H., 2013. "Research Policy and U.S. Economic Growth," MPRA Paper 49103, University Library of Munich, Germany.
- Suppliet, Moritz, 2020.
"Umbrella branding in pharmaceutical markets,"
Journal of Health Economics, Elsevier, vol. 73(C).
- Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Discussion Paper 2017-033, Tilburg University, Center for Economic Research.
- Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Other publications TiSEM 6ee607fc-8602-4270-a076-3, Tilburg University, School of Economics and Management.
- Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Discussion Paper 2017-034, Tilburg University, Tilburg Law and Economic Center.
- Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Other publications TiSEM be3f3c38-5e39-4a67-af57-8, Tilburg University, School of Economics and Management.
- Rosario Crinò & Laura Ogliari, 2014. "Financial Frictions, Product Quality, and International Trade," Working Papers wp2014_1403, CEMFI.
- Lichtenberg Frank R., 2018.
"The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis,"
Forum for Health Economics & Policy, De Gruyter, vol. 21(2), pages 1-20, December.
- Frank R. Lichtenberg, 2019. "The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries: a two-way fixed-effects analysis," CESifo Working Paper Series 7559, CESifo.
- Prettner, Klaus, 2013. "Public education, technological change and economic prosperity," University of Göttingen Working Papers in Economics 149, University of Goettingen, Department of Economics.
- repec:got:cegedp:149 is not listed on IDEAS
- Lichtenberg, Frank R., 2022. "The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries," Economics & Human Biology, Elsevier, vol. 46(C).
- Santos-Arteaga, Francisco J. & Di Caprio, Debora & Tavana, Madjid & O’Connor, Aidan, 2017. "Innovation dynamics and labor force restructuring with asymmetrically developed national innovation systems," International Business Review, Elsevier, vol. 26(1), pages 36-56.
- Schreiner, Lena & Madlener, Reinhard, 2022.
"Investing in power grid infrastructure as a flexibility option: A DSGE assessment for Germany,"
Energy Economics, Elsevier, vol. 107(C).
- Schreiner, Lena & Madlener, Reinhard, 2019. "Investing in power grid infrastructure as a flexibility option: A DSGE assessment for Germany," FCN Working Papers 11/2019, E.ON Energy Research Center, Future Energy Consumer Needs and Behavior (FCN), revised 01 Apr 2020.
- Carlino, Gerald & Kerr, William R., 2015.
"Agglomeration and Innovation,"
Handbook of Regional and Urban Economics, in: Gilles Duranton & J. V. Henderson & William C. Strange (ed.), Handbook of Regional and Urban Economics, edition 1, volume 5, chapter 0, pages 349-404,
Elsevier.
- Gerald A. Carlino & William R. Kerr, 2014. "Agglomeration and innovation," Working Papers 14-26, Federal Reserve Bank of Philadelphia.
- Gerald Carlino & William R. Kerr, 2014. "Agglomeration and Innovation," Harvard Business School Working Papers 15-007, Harvard Business School.
- Carlino, Gerald & Kerr, William R., 2015. "Agglomeration and innovation," Bank of Finland Research Discussion Papers 27/2015, Bank of Finland.
- Gerald Carlino & William R. Kerr, 2014. "Agglomeration and Innovation," NBER Working Papers 20367, National Bureau of Economic Research, Inc.
- Paul S. Segerstrom & Ignat Stepanok, 2018.
"Learning How To Export,"
Scandinavian Journal of Economics, Wiley Blackwell, vol. 120(1), pages 63-92, January.
- Segerstrom, Paul & Stepanok, Ignat, 2010. "Learning How to Export," SSE/EFI Working Paper Series in Economics and Finance 0727, Stockholm School of Economics, revised 16 Sep 2013.
- Segerstrom, Paul S. & Stepanok, Ignat, 2012. "Learning how to export," Kiel Working Papers 1801, Kiel Institute for the World Economy (IfW Kiel).
- James B. Ang & Jakob B. Madsen, 2012.
"Risk capital, private credit, and innovative production,"
Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 45(4), pages 1608-1639, November.
- James B. Ang & Jakob B. Madsen, 2012. "Risk capital, private credit, and innovative production," Canadian Journal of Economics, Canadian Economics Association, vol. 45(4), pages 1608-1639, November.
- James B. Ang & Jakob B. Madsen, 2012. "Risk Capital, Private Credit And Innovative Production," Monash Economics Working Papers 08-12, Monash University, Department of Economics.
- Katharina E. Blankart & Frank R. Lichtenberg, 2022.
"The Effects of Off-label Drug Use on Disability and Medical Expenditure,"
NBER Working Papers
30440, National Bureau of Economic Research, Inc.
- Blankart, Katharina & Lichtenberg, Frank R., 2022. "The effects of off-label drug use on disability and medical expenditure," Ruhr Economic Papers 969, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
- Duranton, Gilles & Puga, Diego, 2014.
"The Growth of Cities,"
Handbook of Economic Growth, in: Philippe Aghion & Steven Durlauf (ed.), Handbook of Economic Growth, edition 1, volume 2, chapter 5, pages 781-853,
Elsevier.
- Gilles Duranton, 2013. "The Growth of U.S. Cities," Revue d'économie régionale et urbaine, Armand Colin, vol. 0(5), pages 857-876.
- Gilles Duranton & Diego Puga, 2013. "The Growth of Cities," Working Papers wp2013_1308, CEMFI.
- Duranton, Gilles & Puga, Diego, 2013. "The growth of cities," CEPR Discussion Papers 9590, C.E.P.R. Discussion Papers.
- Huh, Hyeon-seung & Kim, David, 2013. "An empirical test of exogenous versus endogenous growth models for the G-7 countries," Economic Modelling, Elsevier, vol. 32(C), pages 262-272.
- Colantone, Italo & Crinò, Rosario, 2014.
"New imported inputs, new domestic products,"
Journal of International Economics, Elsevier, vol. 92(1), pages 147-165.
- Italo Colantone & Rosario Crinò, 2011. "New Imported Inputs, New Domestic Products," Development Working Papers 312, Centro Studi Luca d'Agliano, University of Milano.
- Sergei Guriev & Elias Papaioannou, 2022.
"The Political Economy of Populism,"
Journal of Economic Literature, American Economic Association, vol. 60(3), pages 753-832, September.
- Guriev, Sergei & Papaioannou, Elias, 2020. "The Political Economy of Populism," CEPR Discussion Papers 14433, C.E.P.R. Discussion Papers.
- Sergei Guriev & Elias Papaioannou, 2022. "The Political Economy of Populism," Post-Print hal-03874305, HAL.
- Sergei Guriev & Elias Papaioannou, 2022. "The Political Economy of Populism," SciencePo Working papers Main hal-03874305, HAL.
- Klaus Prettner, 2012.
"Public education, technological change and economic prosperity: semi-endogenous growth revisited,"
PGDA Working Papers
9012, Program on the Global Demography of Aging.
- Prettner, Klaus, 2012. "Public education, technological change and economic prosperity: semi-endogenous growth revisited," VfS Annual Conference 2012 (Goettingen): New Approaches and Challenges for the Labor Market of the 21st Century 65414, Verein für Socialpolitik / German Economic Association.
- Herrerias, M.J. & Orts, Vicente, 2013. "Capital goods imports and long-run growth: Is the Chinese experience relevant to developing countries?," Journal of Policy Modeling, Elsevier, vol. 35(5), pages 781-797.
- Peter Mayerhofer & Oliver Fritz & Dieter Pennerstorfer, 2010. "Dritter Bericht zur internationalen Wettbewerbsfähigkeit Wiens," WIFO Studies, WIFO, number 42430.
- Keiichi Kishi, 2015.
"Dynamic analysis of wage inequality and creative destruction,"
Journal of Economics, Springer, vol. 115(1), pages 1-23, May.
- Keiichi Kishi, 2013. "Dynamic analysis of wage inequality and creative destruction," Discussion Papers in Economics and Business 13-20, Osaka University, Graduate School of Economics.
More about this item
Keywords
Medicines possession ratio; Innovation; Vintage; Promotion; Productivity in health care;All these keywords.
JEL classification:
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- C31 - Mathematical and Quantitative Methods - - Multiple or Simultaneous Equation Models; Multiple Variables - - - Cross-Sectional Models; Spatial Models; Treatment Effect Models; Quantile Regressions; Social Interaction Models
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kap:hcarem:v:23:y:2020:i:4:d:10.1007_s10729-020-09513-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.